Literature DB >> 17088692

Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup.

Lars-Olof Wahlund1, Ove Almkvist, Kaj Blennow, Knut Engedahl, Aki Johansson, Gunhild Waldemar, Henrike Wolf.   

Abstract

BACKGROUND: The diagnostic utility of magnetic resonance imaging in dementia workups has increased recently. The basic use is to exclude space-occupying processes in the brain. However, magnetic resonance imaging offers major opportunities for studying atrophy of specific brain areas. A great interest has been put in whether atrophy in the medial temporal lobe can serve as an early diagnostic marker for Alzheimer disease. METHODS AND
RESULTS: In this evaluation, we used evidence-based techniques and reviewed more than 400 articles that address this issue. Our main finding is that a variety of methods in studying brain areas were used, and this made it difficult to extract conclusive information in a systematic way.
CONCLUSION: However, we were able to conclude that atrophy of the hippocampus can distinguish patients with Alzheimer disease from healthy subjects, but there was a lack of evidence because of insufficient studies concerning the usefulness of medial temporal lobe atrophy as a diagnostic marker in a more general setting.

Entities:  

Mesh:

Year:  2005        PMID: 17088692     DOI: 10.1097/01.rmr.0000245463.36148.12

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  15 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 2.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

3.  Connectome-scale assessments of structural and functional connectivity in MCI.

Authors:  Dajiang Zhu; Kaiming Li; Douglas P Terry; A Nicholas Puente; Lihong Wang; Dinggang Shen; L Stephen Miller; Tianming Liu
Journal:  Hum Brain Mapp       Date:  2013-09-30       Impact factor: 5.038

4.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

Review 5.  Annual research review: progress in using brain morphometry as a clinical tool for diagnosing psychiatric disorders.

Authors:  Alexander Haubold; Bradley S Peterson; Ravi Bansal
Journal:  J Child Psychol Psychiatry       Date:  2012-03-07       Impact factor: 8.982

6.  Using Copula distributions to support more accurate imaging-based diagnostic classifiers for neuropsychiatric disorders.

Authors:  Ravi Bansal; Xuejun Hao; Jun Liu; Bradley S Peterson
Journal:  Magn Reson Imaging       Date:  2014-08-02       Impact factor: 2.546

Review 7.  Review of MR elastography applications and recent developments.

Authors:  Kevin J Glaser; Armando Manduca; Richard L Ehman
Journal:  J Magn Reson Imaging       Date:  2012-10       Impact factor: 4.813

Review 8.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01

9.  Label fusion strategy selection.

Authors:  Nicolas Robitaille; Simon Duchesne
Journal:  Int J Biomed Imaging       Date:  2012-02-06

10.  Automatic classification of MR scans in Alzheimer's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Carlton Chu; Bogdan Draganski; Rachael I Scahill; Jonathan D Rohrer; Nick C Fox; Clifford R Jack; John Ashburner; Richard S J Frackowiak
Journal:  Brain       Date:  2008-01-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.